Linzagolix

Therapeutic indications

Linzagolix is indicated for:

Moderate to severe symptoms of uterine fibroids

Population group: women, only adults (18 - 65 years old)

Linzagolix is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Linzagolix is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Osteoporosis

Osteoporosis

Genital bleeding of unknown aetiology

Hemorrhage of genital region

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: YSELTY Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈